IMMUNICON

immunicon-logo

They are developing and commercializing proprietary cell-based research and diagnostic products with an initial focus on cancer. They believe that their current and future products can provide significant clinical benefits by giving physicians better information to understand, diagnose, treat and monitor cancer. They design their products to provide physicians and scientists with clinically meaningful information earlier than current diagnostic methods. Their technologies, which they brand as... CellTracks, can identify, count and characterize the presence and quantity of a small number of tumor cells present in a blood sample. Their collaborator, Veridex, LLC, or Veridex, a Johnson & Johnson company, submitted a pre-market notification, or 510(k), to the US Food and Drug Administration, or FDA, in May 2003 for use of the CellSearch Epithelial Cell Kit in the management of metastatic breast cancer. They expect that the CellSearch Epithelial Cell Kit will be the initial product launched by Veridex based on their technologies. They believe that their products and underlying technology platforms have other applications in cancer diagnostics, in the development of cancer drugs and in cancer research. In addition, they believe that their proprietary technologies may have applications in other fields of medicine, such as cardiovascular and infectious diseases.

#People #Financial #Website #More

IMMUNICON

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical

Founded:
1983-01-01

Address:
Huntingdon Valley, Pennsylvania, United States

Country:
United States

Website Url:
http://www.immunicon.com

Total Employee:
51+

Status:
Active

Total Funding:
53.75 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty AdBlock Acceptable Ads Bodis DNS


Founder


edward-l-erickson_image

Edward L. Erickson

Stock Details


Company's stock symbol is NASDAQ:IMMCQ

Investors List

johnson-johnson-development-corporation_image

Johnson & Johnson Development Corporation

Johnson & Johnson Development Corporation investment in Series F - Immunicon

wheatley-partners_image

Wheatley Partners

Wheatley Partners investment in Series F - Immunicon

burrill-co_image

Burrill & Company

Burrill & Company investment in Series F - Immunicon

tl-ventures_image

TL Ventures

TL Ventures investment in Series F - Immunicon

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series F - Immunicon

Official Site Inspections

http://www.immunicon.com

  • Host name: 199.59.243.227
  • IP address: 199.59.243.227
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Immunicon" on Search Engine